This insight brief explores how remote monitoring has become a core component of modern clinical trials, driven by digital transformation and evolving regulatory expectations. It traces the evolution from traditional on-site monitoring to hybrid and fully remote models supported by Risk-Based Quality Management (RBQM). The brief outlines key remote monitoring techniques, including centralized data review, targeted source data verification, and real-time risk indicators that improve oversight while reducing operational burden. It also examines how the role of Clinical Research Associates (CRAs) is evolving toward analytics-driven oversight and strategic issue resolution. IQVIA’s Functional Service Provider (FSP) experience demonstrates how specialized, scalable teams enable consistent imple

Join for free to read